* Clover Health Investments Corp CLOV.OQ reported a
quarterly
adjusted loss of 17 cents per share for the quarter ended in
December. The mean expectation of six analysts for the quarter
was for a loss of 26 cents per share.
* Revenue rose 108% to $898.79 million from a year ago;
analysts
expected $785.38 million.
* Clover Health Investments Corp's reported EPS for the
quarter
was a loss of 17 cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Clover Health Investments Corp shares had risen by 23.7%
this
quarter.
* The company reported a quarterly loss of $84.05 million.
* Wall Street's median 12-month price target for Clover
Health
Investments Corp is $1.63
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 2 "sell" or "strong sell."
This summary was machine generated from Refinitiv data February
28 at 02:37 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2022 -0.26 -0.17 Beat
Sep. 30 2022 -0.24 -0.16 Beat
Jun. 30 2022 -0.21 -0.22 Missed
Mar. 31 2022 -0.27 -0.19 Beat